COT/tpl2 inhibitors (Array BioPharma)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameCOT/tpl2 inhibitors (Array BioPharma)
Drug Alias NameCOT inhibitors (Array BioPharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase 8 inhibitors
TargetsMitogen-activated protein kinase kinase kinase 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArray Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArray Biopharma Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A